Abstract
Due to its close proximity to the gastrointestinal tract, the normally sterile urinary tract is constantly challenged by microbial invasion. To counter this microbial assault, the urinary tract has developed a highly effective antimicrobial “shield” that can rapidly eliminate invading pathogens or prevent their growth. During recent years, considerable advances have been made in our understanding of the immune mechanisms that contribute to urinary tract sterility. Recent evidence indicates that cationic antimicrobial peptides contribute to the innate host defense of the urinary tract. This chapter reviews the published literature on the role(s) of antimicrobial peptides (AMPs) in maintaining urinary tract sterility.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abrink M, Larsson E, Gobl A, Hellman L (2000) Expression of lactoferrin in the kidney: implications for innate immunity and iron metabolism. Kidney Int 57:2004–2010
Ali AS, Townes CL, Hall J, Pickard RS (2009) Maintaining a sterile urinary tract: the role of antimicrobial peptides. J Urol 182:21–28
Bachur RG, Harper MB (2001) Predictive model for serious bacterial infections among infants younger than 3 months of age. Pediatrics 108:311–316
Bals R, Goldman MJ, Wilson JM (1998) Mouse beta-defensin 1 is a salt-sensitive antimicrobial peptide present in epithelia of the lung and urogenital tract. Infect Immun 66:1225–1232
Bates JM, Raffi HM, Prasadan K, Mascarenhas R, Laszik Z, Maeda N, Hultgren SJ, Kumar S (2004) Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int 65:791–797
Becknell B, Spencer JD, Carpenter AR, Chen X, Singh A, Ploeger S, Kline J, Ellsworth P, Li B, Proksch E, Schwaderer AL, Hains DS, Justice SS, McHugh KM (2013) Expression and antimicrobial function of beta-defensin 1 in the lower urinary tract. PLoS One 8:e77714
Becknell B, Eichler TE, Beceiro S, Li B, Easterling RS, Carpenter AR, James CL, McHugh KM, Hains DS, Partida-Sanchez S, Spencer JD (2015) Ribonucleases 6 and 7 have antimicrobial function in the human and murine urinary tract. Kidney Int 87(1):151–161
Bellamy W, Takase M, Wakabayashi H, Kawase K, Tomita M (1992) Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J Appl Bacteriol 73:472–479
Berger T, Togawa A, Duncan GS, Elia AJ, You-Ten A, Wakeham A, Fong HE, Cheung CC, Mak TW (2006) Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci U S A 103:1834–1839
Boix E, Nogues MV (2007) Mammalian antimicrobial proteins and peptides: overview on the RNase A superfamily members involved in innate host defence. Mol Biosyst 3:317–335
Chassin C, Tourneur E, Bens M, Vandewalle A (2011) A role for collecting duct epithelial cells in renal antibacterial defences. Cell Microbiol 13:1107–1113
Chromek M (2015) The role of the antimicrobial peptide cathelicidin in renal diseases. Pediatr Nephrol 30(8):1225–1232
Chromek M, Slamova Z, Bergman P, Kovacs L, Podracka L, Ehren I, Hokfelt T, Gudmundsson GH, Gallo RL, Agerberth B, Brauner A (2006) The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 12:636–641
Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A (2004) Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432:917–921
Foxman B, Barlow R, D’Arcy H, Gillespie B, Sobel JD (2000) Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 10:509–515
Ganz T (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3:710–720
Harder J, Schroder JM (2002) RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem 277:46779–46784
Haversen LA, Engberg I, Baltzer L, Dolphin G, Hanson LA, Mattsby-Baltzer I (2000) Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice. Infect Immun 68:5816–5823
Hawthorn LA, Bruce AW, Reid G (1991) Ability of uropathogens to bind to Tamm Horsfall protein-coated renal tubular cells. Urol Res 19:301–304
Hertting O, Holm A, Luthje P, Brauner H, Dyrdak R, Jonasson AF, Wiklund P, Chromek M, Brauner A (2010) Vitamin D induction of the human antimicrobial Peptide cathelicidin in the urinary bladder. PLoS One 5:e15580
Hiratsuka T, Nakazato M, Ihi T, Minematsu T, Chino N, Nakanishi T, Shimizu A, Kangawa K, Matsukura S (2000) Structural analysis of human beta-defensin-1 and its significance in urinary tract infection. Nephron 85:34–40
Holmes MA, Paulsene W, Jide X, Ratledge C, Strong RK (2005) Siderocalin (Lcn 2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration. Structure 13:29–41
Huang YC, Lin YM, Chang TW, Wu SJ, Lee YS, Chang MD, Chen C, Wu SH, Liao YD (2007) The flexible and clustered lysine residues of human ribonuclease 7 are critical for membrane permeability and antimicrobial activity. J Biol Chem 282:4626–4633
Huttner KM, Kozak CA, Bevins CL (1997) The mouse genome encodes a single homolog of the antimicrobial peptide human beta-defensin 1. FEBS Lett 413:45–49
Ihi T, Nakazato M, Mukae H, Matsukura S (1997) Elevated concentrations of human neutrophil peptides in plasma, blood, and body fluids from patients with infections. Clin Infect Dis 25:1134–1140
Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, Adermann K (2000) LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480:147–150
Lehrer RI, Lichtenstein AK, Ganz T (1993) Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 11:105–128
Liu L, Zhao C, Heng HH, Ganz T (1997) The human beta-defensin-1 and alpha-defensins are encoded by adjacent genes: two peptide families with differing disulfide topology share a common ancestry. Genomics 43:316–320
Mo L, Zhu XH, Huang HY, Shapiro E, Hasty DL, Wu XR (2004) Ablation of the Tamm-Horsfall protein gene increases susceptibility of mice to bladder colonization by type 1-fimbriated Escherichia coli. Am J Physiol Renal Physiol 286:F795–F802
Morrison GM, Davidson DJ, Kilanowski FM, Borthwick DW, Crook K, Maxwell AI, Govan JR, Dorin JR (1998) Mouse beta defensin-1 is a functional homolog of human beta defensin-1. Mamm Genome 9:453–457
Morrison G, Kilanowski F, Davidson D, Dorin J (2002) Characterization of the mouse beta defensin 1, Defb1, mutant mouse model. Infect Immun 70:3053–3060
Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, Heuser J, Hultgren SJ (1998) Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282:1494–1497
Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ (2000) Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc Natl Acad Sci U S A 97:8829–8835
Navid F, Boniotto M, Walker C, Ahrens K, Proksch E, Sparwasser T, Muller W, Schwarz T, Schwarz A (2012) Induction of regulatory T cells by a murine beta-defensin. J Immunol 188:735–743
Pak J, Pu Y, Zhang ZT, Hasty DL, Wu XR (2001) Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin Ia and Ib receptors. J Biol Chem 276:9924–9930
Paragas N, Qiu A, Zhang Q, Samstein B, Deng SX, Schmidt-Ott KM, Viltard M, Yu W, Forster CS, Gong G, Liu Y, Kulkarni R, Mori K, Kalandadze A, Ratner AJ, Devarajan P, Landry DW, D’Agati V, Lin CS, Barasch J (2011) The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med 17:216–222
Paragas N, Kulkarni R, Werth M, Schmidt-Ott KM, Forster C, Deng R, Zhang Q, Singer E, Klose AD, Shen TH, Francis KP, Ray S, Vijayakumar S, Seward S, Bovino ME, Xu K, Takabe Y, Amaral FE, Mohan S, Wax R, Corbin K, Sanna-Cherchi S, Mori K, Johnson L, Nickolas T, D’Agati V, Lin CS, Qiu A, Al-Awqati Q, Ratner AJ, Barasch J (2014) alpha-Intercalated cells defend the urinary system from bacterial infection. J Clin Invest 124:2963–2976
Park CH, Valore EV, Waring AJ, Ganz T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276:7806–7810
Porter EM, Poles MA, Lee JS, Naitoh J, Bevins CL, Ganz T (1998) Isolation of human intestinal defensins from ileal neobladder urine. FEBS Lett 434:272–276
Porter E, Yang H, Yavagal S, Preza GC, Murillo O, Lima H, Greene S, Mahoozi L, Klein-Patel M, Diamond G, Gulati S, Ganz T, Rice PA, Quayle AJ (2005) Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions. Infect Immun 73:4823–4833
Quayle AJ, Porter EM, Nussbaum AA, Wang YM, Brabec C, Yip KP, Mok SC (1998) Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol 152:1247–1258
Ragnarsdottir B, Svanborg C (2012) Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: host-pathogen interaction in urinary tract infections. Pediatr Nephrol 27:2017–2029
Rosenberg HF (2008) RNase A ribonucleases and host defense: an evolving story. J Leukoc Biol 83:1079–1087
Schutte BC, Mitros JP, Bartlett JA, Walters JD, Jia HP, Welsh MJ, Casavant TL, McCray PB Jr (2002) Discovery of five conserved beta -defensin gene clusters using a computational search strategy. Proc Natl Acad Sci U S A 99:2129–2133
Simanski M, Dressel S, Glaser R, Harder J (2010) RNase 7 protects healthy skin from Staphylococcus aureus colonization. J Invest Dermatol 130:2836–2838
Sobel JD (1997) Pathogenesis of urinary tract infection. Role of host defenses. Infect Dis Clin North Am 11:531–549
Spencer JD, Schwaderer A, McHugh K, Vanderbrink B, Becknell B, Hains DS (2011a) The demographics and costs of inpatient vesicoureteral reflux management in the USA. Pediatr Nephrol 26(11):1995–2001
Spencer JD, Schwaderer AL, Dirosario JD, McHugh KM, McGillivary G, Justice SS, Carpenter AR, Baker PB, Harder J, Hains DS (2011b) Ribonuclease 7 is a potent antimicrobial peptide within the human urinary tract. Kidney Int 80(2):174–180
Spencer JD, Hains DS, Porter E, Bevins CL, DiRosario J, Becknell B, Wang H, Schwaderer AL (2012) Human alpha defensin 5 expression in the human kidney and urinary tract. PLoS One 7:e31712
Spencer JD, Schwaderer AL, Wang H, Bartz J, Kline J, Eichler T, Desouza KR, Sims-Lucas S, Baker P, Hains DS (2013) Ribonuclease 7, an antimicrobial peptide upregulated during infection, contributes to microbial defense of the human urinary tract. Kidney Int 83(4):615–625
Spencer JD, Schwaderer AL, Becknell B, Watson J, Hains DS (2014a) The innate immune response during urinary tract infection and pyelonephritis. Pediatr Nephrol 29(7):1139–1149
Spencer JD, Schwaderer AL, Eichler T, Wang H, Kline J, Justice SS, Cohen DM, Hains DS (2014b) An endogenous ribonuclease inhibitor regulates the antimicrobial activity of ribonuclease 7 in the human urinary tract. Kidney Int 85(5):1179–1191
Tikhonov I, Rebenok A, Chyzh A (1997) A study of interleukin-8 and defensins in urine and plasma of patients with pyelonephritis and glomerulonephritis. Nephrol Dial Transplant 12:2557–2561
Townes CL, Ali A, Robson W, Pickard R, Hall J (2011) Tolerance of bacteriuria after urinary diversion is linked to antimicrobial peptide activity. Urology 77(509):e501–e508
Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PB Jr, Ganz T (1998) Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest 101:1633–1642
van Adelsberg J, Edwards JC, Takito J, Kiss B, al-Awqati Q (1994) An induced extracellular matrix protein reverses the polarity of band 3 in intercalated epithelial cells. Cell 76:1053–1061
Vandewalle A (2008) Toll-like receptors and renal bacterial infections. Chang Gung Med J 31:525–537
Wang AP, Su YP, Shen MQ, Chen F, Chen M, Wang JP (2010) Antibacterial activity and mechanism of recombinant human alpha defensin 5 against clinical antibiotic-resistant strains. Afr J Microbiol Res 4:626–633
Wang H, Schwaderer AL, Kline J, Spencer JD, Kline D, Hains DS (2013) Contribution of structural domains to ribonuclease 7’s activity against uropathogenic bacteria. Antimicrob Agents Chemother 57(2):766–774
Weichhart T, Haidinger M, Horl WH, Saemann MD (2008) Current concepts of molecular defence mechanisms operative during urinary tract infection. Eur J Clin Invest 38(Suppl 2):29–38
Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC (2002) Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 100:3776–3781
Xie Y, Deng S, Thomas CJ, Liu Y, Zhang YQ, Rinderspacher A, Huang W, Gong G, Wyler M, Cayanis E, Aulner N, Tobben U, Chung C, Pampou S, Southall N, Vidovic D, Schurer S, Branden L, Davis RE, Staudt LM, Inglese J, Austin CP, Landry DW, Smith DH, Auld DS (2008) Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activation. Bioorg Med Chem Lett 18:329–335
Yang D, Liu ZH, Tewary P, Chen Q, de la Rosa G, Oppenheim JJ (2007) Defensin participation in innate and adaptive immunity. Curr Pharm Des 13:3131–3139
Zasloff M (2007) Antimicrobial peptides, innate immunity, and the normally sterile urinary tract. J Am Soc Nephrol 18:2810–2816
Zasloff M (2013) The antibacterial shield of the human urinary tract. Kidney Int 83:548–550
Zhou YS, Webb S, Lettice L, Tardif S, Kilanowski F, Tyrrell C, Macpherson H, Semple F, Tennant P, Baker T, Hart A, Devenney P, Perry P, Davey T, Barran P, Barratt CL, Dorin JR (2013) Partial deletion of chromosome 8 beta-defensin cluster confers sperm dysfunction and infertility in male mice. PLoS Genet 9:e1003826
Zucht HD, Grabowsky J, Schrader M, Liepke C, Jurgens M, Schulz-Knappe P, Forssmann WG (1998) Human beta-defensin-1: a urinary peptide present in variant molecular forms and its putative functional implication. Eur J Med Res 3:315–323
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Becknell, B., Spencer, J.D. (2016). Antimicrobial Peptides: Maintaining Sterility of the Urinary Tract. In: Harder, J., Schröder, JM. (eds) Antimicrobial Peptides. Birkhäuser Advances in Infectious Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-24199-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-24199-9_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-24197-5
Online ISBN: 978-3-319-24199-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)